Patents and Applications. All right, title and interest in all patents and patent applications owned by, acquired by, issued to, naming, filed by or on behalf of, Seller or Xxxxxxxx, or in which Seller or Xxxxxxxx have a legal or equitable right of ownership, through the Closing Date, disclosing or claiming any invention, modification, or advance referred to in Section 1.1(i)(a); any further applications claiming a right of priority from such patents or patent applications (including, without limitation, any divisional, continuation, continuation-in-part, or convention applications); and any patents issuing on any such applications; any reissue, reexamination or extension of any such patents; such patents and applications including, by way of non-limiting example, United States Patent Application Serial No. 08/409,317, filed on 3/23/95, entitled "System Permitting the External Replacement of the CPU and/or DRAM XXXXx Microchip Board" (the "Patent Application") and the aforementioned "additional" patent application (not yet filed) referred to in the letter dated December 19, 1996, from Hamirani's counsel to Xx. Xxxxxx X. Kransdorf (the "Additional Patent Application");
Patents and Applications. 11.2(d)(1)(2) Consents
Patents and Applications. [***] 2 The parties hereby agree that Sigilon has no additional rights under Section 2.2. Except as specifically modified or amended hereby, all other terms and conditions of the License Agreement shall remain unchanged and in full force and effect.
Patents and Applications. (i) Issued
Patents and Applications. Schedule 1 contains a correct, current, and complete list of all patents and patent applications related to the Licenses, including the Acquired Patents and the Merck Serono Patents (as defined in the Merck Serono License), specifying as to each, as applicable, the title, the record owner, the jurisdiction in which it has been issued or filed, the patent number or application serial or publication number, and the issue or application filing date. All required filings and fees related to the Acquired Patents listed on Schedule 1 have been timely filed with and paid to the USPTO and other relevant governmental authorities and authorized registrars, and all such patents and patent applications have at all times been and remain in good standing. Seller has provided Buyer with true and complete copies of all documents, certificates, office actions, responses, correspondence, and other filings and materials related to all such Acquired Patents. Seller has satisfied, and will continue to satisfy, all of its obligations to the inventors of the Acquired Patents (if any).
Patents and Applications. PCT Patent Application Serial No. PCT/US99/00088, Filed January 5, 1999, Entitled “Method And Apparatus For Performing Microassays” designating Australia, Canada, all member countries of the EPC, Japan, Republic of Korea EPC Patent Application Serial No. 99901294.1, Filed January 5, 1999, Entitled “Method And Apparatus For Performing Microassays”, designating all member countries of the EPC JP Patent Application Serial No. 2000-527355, Filed January 5, 1999, Entitled “Method And Apparatus For Performing Microassays”. CAN Patent Application Serial No. 2316912, Filed January 5, 1999, Entitled “Method And Apparatus For Performing Microassays”. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. XXXXXXXX X Xxxx xx Xxxxxxxxx (xxxxxxxxx Xxxxxx Xxxxxx) for which PATENT RIGHTS Applications Will Be Filed, Prosecuted and Maintained For all of the following jurisdictions for which PATENT RIGHTS applications are still valid as of the EFFECTIVE DATE: Canada, France, Germany, Ireland, Italy, Japan, Republic of Korea, Spain, Sweden, Switzerland and the United Kingdom. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 406 of the Securities Act. Technology Licensing Office Massachusetts Institute of Technology Five Cambridge Center, Kxxxxxx Square, Room NE25-230 Cxxxxxxxx, Xxxxxxxxxxxxx 00000-0000 Phone 600-000-0000 Fax 600-000-0000 Email txx@xxx.xxx hxxx://xxx.xxx.xxx/xxx/ December 21, 2004. Dear Axxx: Our recent discussions indicate that BioTrove is making progress toward first commercial sale of product but may not be able to meet the impending deadline of December 31, 2004. In addition, we have come to the conclusion that it is not necessary to have Errors & Omissions Insurance coverage until this sale takes place. Therefore, M.I.T. is offering to amend Section 8.2, subsection (iii) of the above referenced license agreement to read as follows: “...shall be endorsed to include product liability coverage and errors and omissions coverage prior to the first commercial sale of a LICENSED PRODUCT...” (emphasis added for convenience).
Patents and Applications. Seed IP Ref. Country Patent No. Issue Date 408 Method of separation of cesium-131 from barium 6,066,302 23-May-2000 407 Brachytherapy implant seeds 7,410,458 12-Aug-2008 401 Method of separating and purifying cesium-131 from barium nitrate 7,479,261 20-Jan-2009 403 Method of separating and purifying cesium-131 from barium carbonate 7,531,150 12-May-2009 405 Method for large scale production of cesium-131 with low cesium-132 content Application 20120142993 406 Method for improving recovery of cesium-131 from barium carbonate 7,510,691 31-Mar-2009 Exhibit E-1 GammaTile, LLC Patent Summary dated January 14, 2017 Carriers Nickname (Country) Status (Due Date) Carriers (AE) Waiting for Initial Examination Carriers (BR) Waiting for Initial Examination Carriers (CA) Requested Examination Carriers (EP) Waiting for further examination Carriers (JP) Office Action Response Due Gores (US) Issued Pxx. No. 8,876,684 Stars & Dots (US) Issued Pxx. No. 9,492,683 Stars & Dots II (US) Waiting for Initial Examination Tiles I (US) Issued Pxx. No. 8,974,364 Tiles II (US) Issued Pxx. No. 9,022,915 Tiles III (US) Issued Pxx. No. 9,545,525 Loaders Injector (US) Issued Pxx. No. 9,403,033 Injector I (US) Waiting for Initial Examination Injector (PCT) National Stage Filings Due Loader (CA) Requested Examination Loader (EP) Waiting for Initial Examination Loader I (US) Issued Pxx. No. 8,939,881 Loader II (US) Issued Pxx. No. 9,409,039 Loader III (US) Waiting for Initial Examination Carrier & Loader (US) Waiting for Initial Examination Transparent Loader (US) Non-Provisional Filing (November 29, 2017) Radiation Shielding Radiation Shielding Devices (US) Issued Patent No. 9,526,463 Radiation Shielding Devices II (US) Waiting for Initial Examination Radiation Shielding Devices (PCT) National Stage Filings Due (11/6/2017) Planning and Surgical Guidance Software Implant Planning and Surgical Guidance (US) OA Response Due (2/10/2017) Design Patents US Issued Pxx. No. D686341 Loader with lid & 2 guide channels US Issued Pxx. No. D686744 Tile carrier with cut marks US Issued Pxx. No. D686745 Gxxx carrier with cut marks US Issued Pxx. No. D686746 Gxxx carrier with extended flap US Issued Pxx. No. D686747 Gxxx carrier with no flap US Issued Pxx. No. D686748 Loader with lid & 1 guide channel US Issued Pxx. No. D687568 Tile carrier array (6x6) US Issued Pxx. No. D687966 Tile carrier array (2x2 or larger) US Issued Pxx. No. D687967 Tile carrier (cut from array)
Patents and Applications. (a) Following the execution of this Agreement, the Licensor shall furnish to the Licensee at its request, or to its nominees and patent attorneys, all information and documents regarding the Technology, including a description of the processes which the Technology incorporates, in order to enable the Licensee to operate hereunder.
Patents and Applications. 1. U.S. Patent No. 5,037,207 to Tomei et al. ......................... 2. U.S. Patent No. 4,877,966 to Tomei et al. ......................... 3. U.S. Patent No. 4,758,727 to Tomei et al. ......................... 4. U.S. Serial No. 08/451,325 ........................................ "Multi-Channel Acquisition Using Integration Sphere," filed May 26, 1995 (WO/US96/06808 PCT of 08/451,325, Filed May 13, 1996)
Patents and Applications. Cornell Reference Country of Filing Application No 3787-02-US United States 11/601,714 0000-00-XX Xxxxx 200680051368.4 3787-05-EP Europe 6837837 3787-06-IN India 4525/DELNP/2008 300991687.2
